The role of PSMA PET imaging - Nat Lester-Coll
@drlestercoll.bsky.social
oncodaily.com/science/psma...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMA #ProstateCancer
@drlestercoll.bsky.social
oncodaily.com/science/psma...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMA #ProstateCancer
Nat Lester-Coll: The role of PSMA PET imaging - OncoDaily
Nat Lester-Coll: The role of PSMA PET imaging / Alan Dal Pra, cancer, Nat Lester-Coll, OncoDaily, Oncology, prostate cancer, PSMA, Sophia Kamran, Vedang Murthy
oncodaily.com
April 26, 2025 at 9:07 PM
The role of PSMA PET imaging - Nat Lester-Coll
@drlestercoll.bsky.social
oncodaily.com/science/psma...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMA #ProstateCancer
@drlestercoll.bsky.social
oncodaily.com/science/psma...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMA #ProstateCancer
Siemens Biograph Vision Quadra PSMA PET scan
August 28, 2026 at 11:01 AM
Siemens Biograph Vision Quadra PSMA PET scan
As someone with stage IV cancer, you hang onto hope = research. Specifically PET PSMA and Pluvicto weren't here 2-3 years ago. I picked my oncologist as he's a Professor who offered potential of trials. Their CDC funding was cut by 85%. Chancellor said "eventually people will die because of this"
April 2, 2025 at 12:20 AM
As someone with stage IV cancer, you hang onto hope = research. Specifically PET PSMA and Pluvicto weren't here 2-3 years ago. I picked my oncologist as he's a Professor who offered potential of trials. Their CDC funding was cut by 85%. Chancellor said "eventually people will die because of this"
Excellent Review on PSMA PET for Prostate Cancer Diagnosis - Sabine D. Brookman-May
@brookmans76.bsky.social
oncodaily.com/science/psma...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMAPET #ProstateCancer
@brookmans76.bsky.social
oncodaily.com/science/psma...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMAPET #ProstateCancer
Sabine D. Brookman-May: Excellent Review on PSMA PET for Prostate Cancer Diagnosis - OncoDaily
Sabine D. Brookman-May: Excellent Review on PSMA PET for Prostate Cancer Diagnosis / cancer, european urology, OncoDaily, Oncology, prostate cancer, PSMA,
oncodaily.com
June 20, 2025 at 9:44 PM
Excellent Review on PSMA PET for Prostate Cancer Diagnosis - Sabine D. Brookman-May
@brookmans76.bsky.social
oncodaily.com/science/psma...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMAPET #ProstateCancer
@brookmans76.bsky.social
oncodaily.com/science/psma...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMAPET #ProstateCancer
PSMA PET Scan: Your Questions Answered
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMA #PETScan #PSMAPETScan #Radiology #Radiotherapy
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMA #PETScan #PSMAPETScan #Radiology #Radiotherapy
PSMA PET Scan: Your Questions Answered - OncoDaily
A PSMA PET scan is an advanced imaging technique that plays a crucial role in managing prostate cancer. It utilizes a radioactive tracer that spec
oncodaily.com
June 29, 2025 at 9:55 PM
PSMA PET Scan: Your Questions Answered
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMA #PETScan #PSMAPETScan #Radiology #Radiotherapy
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PSMA #PETScan #PSMAPETScan #Radiology #Radiotherapy
My PSMA PET CT scan was denied by a pill pushing “doctor” from his jail cell.
September 29, 2026 at 3:34 AM
My PSMA PET CT scan was denied by a pill pushing “doctor” from his jail cell.
Day One of #PROSCA24
Presenter: Dr. Ken Herrmann
Case discussion session: High-risk localised/locally advanced PCa
TOPIC: Regional lymph node staging by PSMA-PET
https://buff.ly/4gaR6Kx
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Presenter: Dr. Ken Herrmann
Case discussion session: High-risk localised/locally advanced PCa
TOPIC: Regional lymph node staging by PSMA-PET
https://buff.ly/4gaR6Kx
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Dr. Herrmann on Regional lymph node staging by PSMA-PET . Day One #PROSCA24
Day One of #PROSCA24Presenter: Dr. Ken HerrmannCase discussion session: High-risk localised/locally advanced PCaTOPIC:Regional lymph node staging by PSMA-PET...
buff.ly
November 29, 2024 at 6:00 PM
Day One of #PROSCA24
Presenter: Dr. Ken Herrmann
Case discussion session: High-risk localised/locally advanced PCa
TOPIC: Regional lymph node staging by PSMA-PET
https://buff.ly/4gaR6Kx
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Presenter: Dr. Ken Herrmann
Case discussion session: High-risk localised/locally advanced PCa
TOPIC: Regional lymph node staging by PSMA-PET
https://buff.ly/4gaR6Kx
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer
www.nature.com/articles/s41...
Suggesting that in patients with negative PSMA PET, PLND might be unnecessary. However, long-term oncologic outcomes were not assessed.
www.nature.com/articles/s41...
Suggesting that in patients with negative PSMA PET, PLND might be unnecessary. However, long-term oncologic outcomes were not assessed.
Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer - Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases - Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer
www.nature.com
January 6, 2025 at 2:44 PM
Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer
www.nature.com/articles/s41...
Suggesting that in patients with negative PSMA PET, PLND might be unnecessary. However, long-term oncologic outcomes were not assessed.
www.nature.com/articles/s41...
Suggesting that in patients with negative PSMA PET, PLND might be unnecessary. However, long-term oncologic outcomes were not assessed.
PSMA PET Guides the Individualized Use of Lutetium-Based Therapies in mCRPC @fredhutch.bsky.social #oncology #CRPC
www.onclive.com/view/psma-pe...
www.onclive.com/view/psma-pe...
PSMA PET Guides the Individualized Use of Lutetium-Based Therapies in mCRPC
Evan Y. Yu, MD, discusses the clinical evolution of radiopharmaceuticals for patients with mCRPC and how PSMA PET may evolve to monitor treatment response.
www.onclive.com
April 22, 2025 at 7:29 PM
PSMA PET Guides the Individualized Use of Lutetium-Based Therapies in mCRPC @fredhutch.bsky.social #oncology #CRPC
www.onclive.com/view/psma-pe...
www.onclive.com/view/psma-pe...
Important to distinguish #serosal findings on #PSMA 🩻vs. #parenchymal
Serosal lesions are better seen on #PSMA vs CT/MRI in #ProstateCancer but likely have an indolent course even with no 🚫therapy (even on the liver!)
Dr. Melissa Abel at el @natrevurol.nature.com
rdcu.be/eBwPs
Serosal lesions are better seen on #PSMA vs CT/MRI in #ProstateCancer but likely have an indolent course even with no 🚫therapy (even on the liver!)
Dr. Melissa Abel at el @natrevurol.nature.com
rdcu.be/eBwPs
Ominous-appearing serosal findings on PSMA imaging might belie indolent clinical course
Nature Reviews Urology - Understanding of metastatic prostate cancer is mainly defined by macroscopic findings, but prostate-specific membrane antigen (PSMA) PET has increased sensitivity. PSMA+...
rdcu.be
August 21, 2025 at 12:02 PM
Important to distinguish #serosal findings on #PSMA 🩻vs. #parenchymal
Serosal lesions are better seen on #PSMA vs CT/MRI in #ProstateCancer but likely have an indolent course even with no 🚫therapy (even on the liver!)
Dr. Melissa Abel at el @natrevurol.nature.com
rdcu.be/eBwPs
Serosal lesions are better seen on #PSMA vs CT/MRI in #ProstateCancer but likely have an indolent course even with no 🚫therapy (even on the liver!)
Dr. Melissa Abel at el @natrevurol.nature.com
rdcu.be/eBwPs
This study suggests that a negative PSMA PET scan can help avoid unnecessary pelvic lymph node dissection in intermediate-risk prostate cancer patients, potentially reducing treatment complications without compromising outcomes. #ProstateCancer #MedicalImaging
Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer - Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases - Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer
www.nature.com
January 8, 2025 at 3:32 PM
This study suggests that a negative PSMA PET scan can help avoid unnecessary pelvic lymph node dissection in intermediate-risk prostate cancer patients, potentially reducing treatment complications without compromising outcomes. #ProstateCancer #MedicalImaging
On demand from #PROSCA24
Presenter: Dr. Ken Herrmann
Case discussion session: High-risk localised/locally advanced #ProstateCancer
TOPIC:Regional lymph node staging by PSMA-PET
buff.ly/4gaR6Kx
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Presenter: Dr. Ken Herrmann
Case discussion session: High-risk localised/locally advanced #ProstateCancer
TOPIC:Regional lymph node staging by PSMA-PET
buff.ly/4gaR6Kx
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Dr. Herrmann on Regional lymph node staging by PSMA-PET . Day One #PROSCA24
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.
buff.ly
December 2, 2024 at 6:29 PM
On demand from #PROSCA24
Presenter: Dr. Ken Herrmann
Case discussion session: High-risk localised/locally advanced #ProstateCancer
TOPIC:Regional lymph node staging by PSMA-PET
buff.ly/4gaR6Kx
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Presenter: Dr. Ken Herrmann
Case discussion session: High-risk localised/locally advanced #ProstateCancer
TOPIC:Regional lymph node staging by PSMA-PET
buff.ly/4gaR6Kx
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Major systematic review on PSMA PET in prostate cancer concludes "PSMA PET cannot be used alone to determine the need for lymph node dissection (LND)." Time to end the practice of negative PSMA PET = no LND sciencedirect.com/science/arti...
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive T...
Positron emission tomography (PET) with prostate-specific membrane antigen (PSMA) in the diagnosis and primary staging of patients with prostate cance…
sciencedirect.com
June 3, 2025 at 4:42 PM
Major systematic review on PSMA PET in prostate cancer concludes "PSMA PET cannot be used alone to determine the need for lymph node dissection (LND)." Time to end the practice of negative PSMA PET = no LND sciencedirect.com/science/arti...
Whole-body PET was performed w/18F-FDG, 68Ga-PSMA-617, and 68Ga-DOTATATE. IIH was found in 82.7% undergoing 18F-FDG and 68Ga-PSMA-617 scans, and 83.8% who had the follow-up 68Ga-DOTATATE scan. Of that 83.8%, 16.2% had positive lesions. 12 different mCRPC IIH phenotypes were found.
November 14, 2024 at 9:21 PM
Whole-body PET was performed w/18F-FDG, 68Ga-PSMA-617, and 68Ga-DOTATATE. IIH was found in 82.7% undergoing 18F-FDG and 68Ga-PSMA-617 scans, and 83.8% who had the follow-up 68Ga-DOTATATE scan. Of that 83.8%, 16.2% had positive lesions. 12 different mCRPC IIH phenotypes were found.
Day One of #PROSCA24
Presenter: Dr Karolien Goffin
Biochemical recurrence following ocal therapy
PSMA-PET in BCR – what to expect?
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Presenter: Dr Karolien Goffin
Biochemical recurrence following ocal therapy
PSMA-PET in BCR – what to expect?
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
November 29, 2024 at 1:20 PM
Day One of #PROSCA24
Presenter: Dr Karolien Goffin
Biochemical recurrence following ocal therapy
PSMA-PET in BCR – what to expect?
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Presenter: Dr Karolien Goffin
Biochemical recurrence following ocal therapy
PSMA-PET in BCR – what to expect?
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Conventional imaging understages high-risk nonmetastatic prostate cancer.
☢️PSMA-PET was positive in 84% of cases, detecting M1 disease in 46%, polymetastatic in 24%.
#ProstateCancer #PSMAPET #Oncology @oncoalert.bsky.social @mjmorrismd.bsky.social
doi:10.1001/jamanetworkopen.2024.52971
☢️PSMA-PET was positive in 84% of cases, detecting M1 disease in 46%, polymetastatic in 24%.
#ProstateCancer #PSMAPET #Oncology @oncoalert.bsky.social @mjmorrismd.bsky.social
doi:10.1001/jamanetworkopen.2024.52971
January 4, 2025 at 9:28 AM
Conventional imaging understages high-risk nonmetastatic prostate cancer.
☢️PSMA-PET was positive in 84% of cases, detecting M1 disease in 46%, polymetastatic in 24%.
#ProstateCancer #PSMAPET #Oncology @oncoalert.bsky.social @mjmorrismd.bsky.social
doi:10.1001/jamanetworkopen.2024.52971
☢️PSMA-PET was positive in 84% of cases, detecting M1 disease in 46%, polymetastatic in 24%.
#ProstateCancer #PSMAPET #Oncology @oncoalert.bsky.social @mjmorrismd.bsky.social
doi:10.1001/jamanetworkopen.2024.52971
Do #PSMA+ findings in #BCR #ProstateCancer require immediate treatment?
NO based on emerging data @theNCI
Appreciate @tiansterzhangmd.bsky.social & #Urotoday for the opportunity to discuss
Ongoing trial of PSMA scans in BCR is still enrolling shorturl.at/36nGQ
www.urotoday.com/categories-m...
NO based on emerging data @theNCI
Appreciate @tiansterzhangmd.bsky.social & #Urotoday for the opportunity to discuss
Ongoing trial of PSMA scans in BCR is still enrolling shorturl.at/36nGQ
www.urotoday.com/categories-m...
PSMA PET in Biochemical Recurrence: When to Treat vs When to Wait - Ravi Madan
Tian Zhang interviews Ravi Madan about a prospective study monitoring PSMA PET-positive biochemically recurrent prostate cancer patients. The trial enrolls patients with PSA > 0.5 and negative convent...
www.urotoday.com
July 18, 2025 at 1:14 PM
Do #PSMA+ findings in #BCR #ProstateCancer require immediate treatment?
NO based on emerging data @theNCI
Appreciate @tiansterzhangmd.bsky.social & #Urotoday for the opportunity to discuss
Ongoing trial of PSMA scans in BCR is still enrolling shorturl.at/36nGQ
www.urotoday.com/categories-m...
NO based on emerging data @theNCI
Appreciate @tiansterzhangmd.bsky.social & #Urotoday for the opportunity to discuss
Ongoing trial of PSMA scans in BCR is still enrolling shorturl.at/36nGQ
www.urotoday.com/categories-m...
With #GU26 approaching one key bit of data missing in the context of #PSMA+ #BCR #ProstateCancer management in the wake of the #EMBARK data is how does #PSA Doubling Time interface w/ #PSMA Pet findings.
Dr. Melissa Abel @ the NCI will share this data @ #GU26 @ascocancer.bsky.social
Dr. Melissa Abel @ the NCI will share this data @ #GU26 @ascocancer.bsky.social
February 13, 2026 at 2:57 PM
With #GU26 approaching one key bit of data missing in the context of #PSMA+ #BCR #ProstateCancer management in the wake of the #EMBARK data is how does #PSA Doubling Time interface w/ #PSMA Pet findings.
Dr. Melissa Abel @ the NCI will share this data @ #GU26 @ascocancer.bsky.social
Dr. Melissa Abel @ the NCI will share this data @ #GU26 @ascocancer.bsky.social
MRT, Biopsie, PSMa Pet/ Ct und ggf OP oder Bestrahlung.
March 28, 2026 at 7:06 PM
MRT, Biopsie, PSMa Pet/ Ct und ggf OP oder Bestrahlung.
Prostate cancer update: my PSA continues to rise, albeit slowly. It’s currently at 0.2, and if it gets to 0.4 I get to have a scan called a PSMA PET. But it’s sluggish enough that I’m dropping back to 6-monthly blood tests from 3-monthly, so that’s something.
November 26, 2024 at 3:12 AM
Prostate cancer update: my PSA continues to rise, albeit slowly. It’s currently at 0.2, and if it gets to 0.4 I get to have a scan called a PSMA PET. But it’s sluggish enough that I’m dropping back to 6-monthly blood tests from 3-monthly, so that’s something.
PSMA PET imaging (radioisotope independent) revolutionizes prostate cancer BCR detection, offering superior sensitivity at low PSA levels, aiding treatment decisions.
November 28, 2024 at 8:59 AM
PSMA PET imaging (radioisotope independent) revolutionizes prostate cancer BCR detection, offering superior sensitivity at low PSA levels, aiding treatment decisions.
Norway Grants Marketing Authorization to Illuccix PSMA-PET Imaging Agent in Prostate Cancer
#PCSM #Oncology
www.onclive.com/view/norway-...
#PCSM #Oncology
www.onclive.com/view/norway-...
Norway Grants Marketing Authorization to Illuccix PSMA-PET Imaging Agent in Prostate Cancer
NOMA has approved the PET imaging agent for the identification of PSMA-positive lesions in patients with prostate cancer.
www.onclive.com
March 5, 2025 at 4:15 PM
Norway Grants Marketing Authorization to Illuccix PSMA-PET Imaging Agent in Prostate Cancer
#PCSM #Oncology
www.onclive.com/view/norway-...
#PCSM #Oncology
www.onclive.com/view/norway-...
Bei uns bekommt man dann einen Brief der KK die nach der Indikation fragt… tja gibt es dann nicht…
(Wenn es zB ein PSMA Pet und ein FDG Pet zum
mismatchausschluss vor Lutetium PSMA Therapie wäre ginge es schon)
(Wenn es zB ein PSMA Pet und ein FDG Pet zum
mismatchausschluss vor Lutetium PSMA Therapie wäre ginge es schon)
November 13, 2025 at 6:41 PM
Bei uns bekommt man dann einen Brief der KK die nach der Indikation fragt… tja gibt es dann nicht…
(Wenn es zB ein PSMA Pet und ein FDG Pet zum
mismatchausschluss vor Lutetium PSMA Therapie wäre ginge es schon)
(Wenn es zB ein PSMA Pet und ein FDG Pet zum
mismatchausschluss vor Lutetium PSMA Therapie wäre ginge es schon)
Is there a role of PSMA-PET in focal therapy planning and follow-up? A Review out on Prostate Cancer
www.nature.com/articles/s41...
Systematic review aims to summarize current applications of PSMA-PET in FT and its future perspectives.
@oncoalert.bsky.social 🚨
@barbaramelao.bsky.social
www.nature.com/articles/s41...
Systematic review aims to summarize current applications of PSMA-PET in FT and its future perspectives.
@oncoalert.bsky.social 🚨
@barbaramelao.bsky.social
Is there a role of PSMA-PET in focal therapy planning and follow-up? - Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases - Is there a role of PSMA-PET in focal therapy planning and follow-up?
www.nature.com
February 18, 2025 at 11:25 AM
Is there a role of PSMA-PET in focal therapy planning and follow-up? A Review out on Prostate Cancer
www.nature.com/articles/s41...
Systematic review aims to summarize current applications of PSMA-PET in FT and its future perspectives.
@oncoalert.bsky.social 🚨
@barbaramelao.bsky.social
www.nature.com/articles/s41...
Systematic review aims to summarize current applications of PSMA-PET in FT and its future perspectives.
@oncoalert.bsky.social 🚨
@barbaramelao.bsky.social